Some links earn us a small commission from Shopee. It never changes your price.
Beauty › Skincare · La Roche Posay

La Roche-Posay Mela B3 Double Dose Serum (40ml) – Anti-Dark Spot Concentrate​

S$84.90S$99.90Save S$15.00
★ 4.9rating
36sold
81likes
Sold by La Roche Posay Official Store★ 4.9Official shop

Price shown is from our latest update and may change. Affiliate link.

Currently priced at S$84.90 (usually S$99.90), this pick comes from La Roche Posay Official Store — an official brand store. Shoppers have bought 36 and rate it 4.9 out of 5.

Product description

Product Highlights​ 🎯 Intense Correction: Visibly fades persistent dark spots, sun spots, and age spots.​ 🛡 Melasyl™ Infused: Multi-patented active targets and intercepts excess melanin before it marks skin.​ ⚖ Anti-Recurrence: Clinically proven to correct uneven skin tone and prevent its return.​ ​ Description​ What is it?​ La Roche-Posay Mela B3 Double Dose Serum is an ultra-concentrated anti-dark spot treatment. Powered by multi-patented Melasyl™ and 10% Niacinamide, this advanced daily serum targets stubborn hyperpigmentation, uneven skin tone, and post- acne marks to restore a uniform, glowing complexion.​ Key Ingredients​ Melasyl™: A breakthrough, patented active that targets excess melanin to prevent and fade dark spots.​ 10% Niacinamide (Vitamin B3): Visibly clarifies existing discoloration and strengthens the skin barrier.​ LHA & Retinyl Palmitate: Gentle exfoliants that promote cell renewal for smoother skin.​ Carnosine: A powerful antioxidant that helps protect skin cells from oxidative stress.​ Main Benefits​ Visibly reduces the size, color, and number of stubborn dark spots.​ Brightens the overall complexion and evens out skin tone.​ Helps prevent the recurrence of dark spots over time.​ Delivers deep, comfortable hydration while refining skin texture.​ Results​ Visibly improves skin clarity within two weeks of daily use.​ Clinically proven to reduce persistent dark spots and hyperpigmentation.​ Helps skin feel instantly softer, smoother, and more…